An exchange-traded fund providing exposure to U.S. pharmaceutical manufacturers, typically tracking the Dow Jones U.S. Select Pharmaceuticals Index. The portfolio is concentrated in large-cap drugmakers engaged in branded and generic drug development, production, and commercialization. Investors mon...
4 members of Congress have disclosed 5 trades in iShares U.S. Pharmaceuticals ETF (IHE), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-02-03 | ROBERT J. WITTMAN | buy | $1K – $15K |
| 2018-01-31 | William Cassidy | sell | $1K – $15K |
| 2015-08-27 | William Cassidy | buy | $1K – $15K |
| 2015-07-27 | Rubén Hinojosa | sell | $1K – $15K |
| 2015-02-04 | MICK MULVANEY | sell | $15K – $50K |